Cendes Co., Ltd. (300492.SZ) shareholder Zhang Peng plans to reduce his stake by no more than 0.19%.
Huatu Shanding (300492.SZ) announced that shareholder Zhang Peng, holding 0.19% of the shares, plans to reduce his holdings by a total of no more than 36,670 shares (equivalent to 0.19% of the total share capital excluding the shares held in the company's repurchase special account) through centralized bidding within three months after the date of disclosure in the announcement (December 25, 2025 to March 24, 2026).
Cendes Co., Ltd. (300492.SZ) announced that shareholder Zhang Peng, holding 0.19% of the shares, plans to reduce the company's shares through centralized bidding within three months after the disclosure of the announcement (December 25, 2025 to March 24, 2026), with a total of no more than 366,700 shares (i.e., no more than 0.19% of the total share capital excluding the shares held in the company's repurchase special securities account).
Related Articles
LIVZON PHARMA (01513): NS-041 tablet has obtained drug clinical trial approval notice for the new indication of treating depression.
QINGDAO PORT (06198) plans to invest 6.615 billion yuan to construct the Dongjiakou general wharf project.
QINGDAO PORT (06198) plans to invest in the construction of the first phase of Dongjiakou Container Terminal. The estimated investment for the project is approximately 9.097 billion yuan.
LIVZON PHARMA (01513): NS-041 tablet has obtained drug clinical trial approval notice for the new indication of treating depression.
QINGDAO PORT (06198) plans to invest 6.615 billion yuan to construct the Dongjiakou general wharf project.
QINGDAO PORT (06198) plans to invest in the construction of the first phase of Dongjiakou Container Terminal. The estimated investment for the project is approximately 9.097 billion yuan.
